Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer
Active, not recruiting · NCT02568839 · Registry updated 2020-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 / Phase 3 | 2020-08-13 | NCT02568839 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Thomas Hatschek | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dept. of Oncology, Karolinska University Hospital | Stockholm | Sweden | 1 |
| Dept. of Oncology, Sahlgrenska University Hospital | Gothenburg | Sweden | 1 |
| Dept. of Oncology, Skåne University Hospital | Lund | Sweden | 1 |
| Dept. of Oncology, Sundsvall Hospital | Sundsvall | Sweden | 1 |
| Dept. of Oncology, University Hospital of Umeå | Umeå | Sweden | 1 |
| Dept. of Oncology, Uppsala University Hospital | Uppsala | Sweden | 1 |
| Dept. of Oncology, Örebro University Hospital | Örebro | Sweden | 1 |